InvestorsObserver
×
News Home

Is Codexis, Inc. (CDXS) a Good Choice in Biotechnology Friday?

Friday, June 24, 2022 12:54 PM | InvestorsObserver Analysts

Mentioned in this article

Is Codexis, Inc. (CDXS) a Good Choice in Biotechnology Friday?

The 63 rating InvestorsObserver gives to Codexis, Inc. (CDXS) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 77 percent of stocks in the Biotechnology industry, CDXS’s 63 overall rating means the stock scores better than 63 percent of all stocks.

Overall Score - 63
CDXS has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on CDXS!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Codexis, Inc. Stock Today?

Codexis, Inc. (CDXS) stock is trading at $10.91 as of 12:54 PM on Friday, Jun 24, an increase of $0.47, or 4.55% from the previous closing price of $10.43. The stock has traded between $10.43 and $10.94 so far today. Volume today is below average. So far 430,655 shares have traded compared to average volume of 840,891 shares. Click Here to get the full Stock Report for Codexis, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App